Cargando…

The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: Involvement of aryl hydrocarbon receptor in mechanism of action

After a traumatic insult, macrophages can become activated leading to general inflammation at the site of injury. Activated macrophages are partially regulated by the aryl hydrocarbon receptor (AhR) which when activated suppresses inflammation by limiting the secretion of pro-inflammatory cytokines...

Descripción completa

Detalles Bibliográficos
Autores principales: Rael, Leonard T., Bar-Or, Raphael, Banton, Kaysie L., Mains, Charles W., Roshon, Michael, Tanner, Allen H., Lieser, Mark J., Acuna, David L., Bar-Or, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068081/
https://www.ncbi.nlm.nih.gov/pubmed/30073204
http://dx.doi.org/10.1016/j.bbrep.2018.06.006
_version_ 1783343204511252480
author Rael, Leonard T.
Bar-Or, Raphael
Banton, Kaysie L.
Mains, Charles W.
Roshon, Michael
Tanner, Allen H.
Lieser, Mark J.
Acuna, David L.
Bar-Or, David
author_facet Rael, Leonard T.
Bar-Or, Raphael
Banton, Kaysie L.
Mains, Charles W.
Roshon, Michael
Tanner, Allen H.
Lieser, Mark J.
Acuna, David L.
Bar-Or, David
author_sort Rael, Leonard T.
collection PubMed
description After a traumatic insult, macrophages can become activated leading to general inflammation at the site of injury. Activated macrophages are partially regulated by the aryl hydrocarbon receptor (AhR) which when activated suppresses inflammation by limiting the secretion of pro-inflammatory cytokines and promoting the over expression of immuno-modulatory mediators. This study aims to determine whether the low molecular weight fraction of 5% human serum albumin (LMWF5A) and N-acetyl kynurenine (NAK), an N-acetyl tryptophan (NAT) breakdown product in LMWF5A, can regulate inflammation by inhibiting macrophage activation through the AhR since kynurenine is a known AhR agonist. Using LCMS, we demonstrate that NAT is non-enzymatically degraded during accelerated aging of LMWF5A with high heat accelerating degradation. More importantly, NAK is a major degradation product found in LMWF5A. THP-1 monocytes were differentiated into macrophages using phorbol 12-myristate 13-acetate (PMA) and pre-treated with 2-fold dilutions of LMWF5A or synthetic NAK with or without an AhR antagonist (CH223191) prior to overnight stimulation with lipopolysaccharide (LPS). Treatment with LMWF5A caused a 50–70% decrease in IL-6 release throughout the dilution series. A dose-response inhibition of IL-6 release was observed for NAK with maximal inhibition (50%) seen at the highest NAK concentration. Finally, an AhR antagonist partially blocked the anti-inflammatory effect of LMWF5A while completely blocking the effect of NAK. A similar inhibitory effect was observed for CXCL-10, but the AhR antagonist was not effective suggesting additional mechanisms for CXCL-10 release. These preliminary findings suggest that LMWF5A and NAK partially promote the suppression of activated macrophages via the AhR receptor. Therefore, LMWF5A, which contains NAK, is potentially a useful therapeutic in medical conditions where inflammation is prevalent such as trauma, sepsis, and wound healing.
format Online
Article
Text
id pubmed-6068081
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-60680812018-08-02 The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: Involvement of aryl hydrocarbon receptor in mechanism of action Rael, Leonard T. Bar-Or, Raphael Banton, Kaysie L. Mains, Charles W. Roshon, Michael Tanner, Allen H. Lieser, Mark J. Acuna, David L. Bar-Or, David Biochem Biophys Rep Research Article After a traumatic insult, macrophages can become activated leading to general inflammation at the site of injury. Activated macrophages are partially regulated by the aryl hydrocarbon receptor (AhR) which when activated suppresses inflammation by limiting the secretion of pro-inflammatory cytokines and promoting the over expression of immuno-modulatory mediators. This study aims to determine whether the low molecular weight fraction of 5% human serum albumin (LMWF5A) and N-acetyl kynurenine (NAK), an N-acetyl tryptophan (NAT) breakdown product in LMWF5A, can regulate inflammation by inhibiting macrophage activation through the AhR since kynurenine is a known AhR agonist. Using LCMS, we demonstrate that NAT is non-enzymatically degraded during accelerated aging of LMWF5A with high heat accelerating degradation. More importantly, NAK is a major degradation product found in LMWF5A. THP-1 monocytes were differentiated into macrophages using phorbol 12-myristate 13-acetate (PMA) and pre-treated with 2-fold dilutions of LMWF5A or synthetic NAK with or without an AhR antagonist (CH223191) prior to overnight stimulation with lipopolysaccharide (LPS). Treatment with LMWF5A caused a 50–70% decrease in IL-6 release throughout the dilution series. A dose-response inhibition of IL-6 release was observed for NAK with maximal inhibition (50%) seen at the highest NAK concentration. Finally, an AhR antagonist partially blocked the anti-inflammatory effect of LMWF5A while completely blocking the effect of NAK. A similar inhibitory effect was observed for CXCL-10, but the AhR antagonist was not effective suggesting additional mechanisms for CXCL-10 release. These preliminary findings suggest that LMWF5A and NAK partially promote the suppression of activated macrophages via the AhR receptor. Therefore, LMWF5A, which contains NAK, is potentially a useful therapeutic in medical conditions where inflammation is prevalent such as trauma, sepsis, and wound healing. Elsevier 2018-07-11 /pmc/articles/PMC6068081/ /pubmed/30073204 http://dx.doi.org/10.1016/j.bbrep.2018.06.006 Text en © 2018 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
Rael, Leonard T.
Bar-Or, Raphael
Banton, Kaysie L.
Mains, Charles W.
Roshon, Michael
Tanner, Allen H.
Lieser, Mark J.
Acuna, David L.
Bar-Or, David
The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: Involvement of aryl hydrocarbon receptor in mechanism of action
title The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: Involvement of aryl hydrocarbon receptor in mechanism of action
title_full The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: Involvement of aryl hydrocarbon receptor in mechanism of action
title_fullStr The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: Involvement of aryl hydrocarbon receptor in mechanism of action
title_full_unstemmed The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: Involvement of aryl hydrocarbon receptor in mechanism of action
title_short The anti-inflammatory effect of LMWF5A and N-acetyl kynurenine on macrophages: Involvement of aryl hydrocarbon receptor in mechanism of action
title_sort anti-inflammatory effect of lmwf5a and n-acetyl kynurenine on macrophages: involvement of aryl hydrocarbon receptor in mechanism of action
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068081/
https://www.ncbi.nlm.nih.gov/pubmed/30073204
http://dx.doi.org/10.1016/j.bbrep.2018.06.006
work_keys_str_mv AT raelleonardt theantiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction
AT barorraphael theantiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction
AT bantonkaysiel theantiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction
AT mainscharlesw theantiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction
AT roshonmichael theantiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction
AT tannerallenh theantiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction
AT liesermarkj theantiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction
AT acunadavidl theantiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction
AT barordavid theantiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction
AT raelleonardt antiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction
AT barorraphael antiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction
AT bantonkaysiel antiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction
AT mainscharlesw antiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction
AT roshonmichael antiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction
AT tannerallenh antiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction
AT liesermarkj antiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction
AT acunadavidl antiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction
AT barordavid antiinflammatoryeffectoflmwf5aandnacetylkynurenineonmacrophagesinvolvementofarylhydrocarbonreceptorinmechanismofaction